发明名称 |
VAKZINE, WELCHE GP120 ZUSAMMEN MIT NEF UND/ODER TAT ENTHÄLT, ZUR IMMUNISIERUNG GEGEN HIV |
摘要 |
<p>Use of a) an HIV Tat protein or polynucleotide; or b) an HIV Nef protein or polynucleotide; or c) an HIV Tat protein or polynucleotide linked to an HIV Nef protein or polynucleotide: and an HIV gp 120 protein or polynucleotide in the manufacture of a vaccine suitable for a prime-boost delivery for the prophylactic or therapeutic immunisation of humans against HIV, wherein the protein or polynucleotide is delivered via a bombardment approach.</p> |
申请公布号 |
DE60239682(D1) |
申请公布日期 |
2011.05.19 |
申请号 |
DE2002639682 |
申请日期 |
2002.07.26 |
申请人 |
GLAXO GROUP LIMITED;GLAXOSMITHKLINE BIOLOGICALS S.A. |
发明人 |
ERTL, PETER FRANZ;TITE, JOHN PHILIP;VAN WELY, CATHERINE ANN;VOSS, GERALD |
分类号 |
A61K39/21;C12N15/09;A61K9/00;A61K31/7088;A61K31/711;A61K31/713;A61K35/76;A61K38/00;A61K39/00;A61K47/02;A61K48/00;A61P31/18;A61P37/04;C07K14/16;C07K19/00;C12N15/49;C12N15/89 |
主分类号 |
A61K39/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|